Russian pharmaceutical companies lag behind foreign ones in terms of drug innovation
Although most players in the Russian pharmaceutical industry call the creation of new drugs important for themselves, they invest little...
Although most players in the Russian pharmaceutical industry call the creation of new drugs important for themselves, they invest little...
According to the Central Bank's calculations, due to rising rates on liabilities, banks may lose 600 billion rubles. until next...
The Accounts Chamber (CA) announced the risks of shortfalls in projected revenues to the federal budget. According to her report,...